Label: VAPOR INHALER LEVMETAMFETAMINE NASAL DECONGESTANT, EQUALINE- levmetamfetamine inhalant

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 20, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (per inhaler)

    Levmetamfetamine 50 mg

  • Purpose

    Nasal decongestant

  • Use:

    for temporary relief of nasal congestion due to:

    • the common cold
    • hay fever or upper respiratory allergies
  • Warnings

    When using this product

    • do not exceed recommended dosage
    • temporary burning, stinging, sneezing, or increased nasal discharge may occur
    • use of this container by more than one person may spread infection
    • do not use for more than 7 days
    • use only as directed
    • frequent or prolonged use may cause nasal congestion to recur or worsen

    Stop use and ask a doctor if symptoms persist

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • the product delivers in each 800 mL of air 0.04 to 0.150 mg of levmetamfetamine
    • do not use more often than every 2 hours
    adults and children 12 years of age and over 2 inhalations in each nostril
    children 6 to under 12 years of age (with adult supervision) 1 inhalation in each nostril
    children under 6 years of age ask a doctor
    children under 2 years of age do not use
  • Other information

    • this inhaler is effective for a minimum of 3 months after first use
    • keep inhaler tightly closed
    • store at 59°-86° F (15°-30° C)
  • Inactive ingredients

    bornyl acetate, camphor, lavender oil, menthol, methyl salicylate

  • Questions or comments?

    1-877-932-7948

  • Principal Display Panel - 198 mg Blister Pack Label

    NDC 41163-031-01

    compare to Original
    Vicks    ® Vapolnhaler®
    active ingredient*

    EQUALINE®

    nasal decongestant

    vapor inhaler

    levmetamfetamine
    (nasal decongestant)

    temporary relief of
    nasal congestion due to:

    • colds • hay fever
    • upper respiratory allergies

    NET WT .007 OZ (198mg)

    Principal Display Panel - 198 mg Blister Pack Label
  • Principal Display Panel - 198 mg Blister Pack Label

    EQUALINE®

    NDC 41163-031-01

    nasal decongestant

    vapor inhaler

    levmetamfetamine (nasal decongestant)

    NET WT .007 OZ (198mg)

    Principal Display Panel - 198 mg Blister Pack Label
  • INGREDIENTS AND APPEARANCE
    VAPOR INHALER   LEVMETAMFETAMINE NASAL DECONGESTANT, EQUALINE
    levmetamfetamine inhalant
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41163-031
    Route of AdministrationNASAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Levmetamfetamine (UNII: Y24T9BT2Q2) (Levmetamfetamine - UNII:Y24T9BT2Q2) Levmetamfetamine50 mg
    Inactive Ingredients
    Ingredient NameStrength
    Bornyl acetate (UNII: 213431586X)  
    Camphor (Synthetic) (UNII: 5TJD82A1ET)  
    Lavender oil (UNII: ZBP1YXW0H8)  
    Menthol (UNII: L7T10EIP3A)  
    Methyl Salicylate (UNII: LAV5U5022Y)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:41163-031-011 in 1 BLISTER PACK02/24/2021
    1198 in 1 INHALER; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01202/24/2021
    Labeler - Supervalu Inc. (943556183)
    Registrant - Aphena Pharma Solutions MD, LLC (829739833)
    Establishment
    NameAddressID/FEIBusiness Operations
    Aphena Pharma Solutions MD, LLC829739833MANUFACTURE(41163-031)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!